T cells of colorectal cancer patients’ stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells
Background Patients with cancers that exhibit extraordinarily high somatic mutation numbers are ideal candidates for immunotherapy and enable identifying tumor-specific peptides through stimulation of tumor-reactive T cells (Tc).Methods Colorectal cancers (CRC) HROC113 and HROC285 were selected base...
Main Authors: | Peter Bauer, Hans-Georg Rammensee, Nadine Mockel-Tenbrinck, Andrzej Dzionek, Andreas Schlosser, Michael Ghosh, Markus W Löffler, Sandra Schwarz, Johanna Schmitz, Evgenia Olshvang, Marvin Markel, Susann Krake, Basak Arslan, Kapil Dev Kampe, Anne Wendt, Christina S Mullins, Michael Linnebacher |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-12-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/12/e005651.full |
Similar Items
-
The HROC-Xenobank—A High Quality Assured PDX Biobank of >100 Individual Colorectal Cancer Models
by: Stephanie Matschos, et al.
Published: (2021-11-01) -
Lymphoma neoantigens
by: Joshua E. Elias
Published: (2018-06-01) -
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
by: Sivan Seliktar-Ofir, et al.
Published: (2017-10-01) -
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
by: Markus W. Löffler, et al.
Published: (2019-04-01) -
Neoantigens in Hematologic Malignancies
by: Melinda A. Biernacki, et al.
Published: (2020-02-01)